Thomas Landkildehus Lisle

Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine

Mathieu Gigoux, Morten Orebo Holmström, Roberta Zappasodi et al. · Science Translational Medicine · 2022 · 28 citations · Full text

Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells

Stine Emilie Weis-Banke, Thomas Landkildehus Lisle, Maria Perez-Penco et al. · Journal for ImmunoTherapy of Cancer · 2022 · 16 citations · Full text

Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

Rasmus Erik Johansson Mortensen, Morten Orebo Holmström, Thomas Landkildehus Lisle et al. · Journal for ImmunoTherapy of Cancer · 2023 · 15 citations · Full text

Sortilin Modulates Schwann Cell Signaling and Remak Bundle Regeneration Following Nerve Injury

Maj Ulrichsen, Nádia Pereira Gonçalves, Simin Mohseni et al. · Frontiers in Cellular Neuroscience · 2022 · 13 citations · Full text

An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial

Jacob Handlos Grauslund, Morten Orebo Holmström, Evelina Martinenaite et al. · Frontiers in Immunology · 2023 · 12 citations · Full text